{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:02:28Z","timestamp":1790521348552,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5 F31 CA236484-02"],"award-info":[{"award-number":["5 F31 CA236484-02"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cellsig.2021.110028","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T12:10:41Z","timestamp":1619784641000},"page":"110028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["The role of the extracellular matrix protein TGFBI in cancer"],"prefix":"10.1016","volume":"84","author":[{"given":"Armando","family":"Corona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard C.","family":"Blobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cellsig.2021.110028_bb0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/dna.1992.11.511","article-title":"cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta","volume":"11","author":"Skonier","year":"1992","journal-title":"DNA Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0010","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/jcp.1041600314","article-title":"cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium","volume":"160","author":"Escribano","year":"1994","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ng0397-247","article-title":"Kerato-epithelin mutations in four 5q31-linked corneal dystrophies","volume":"15","author":"Munier","year":"1997","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00223-014-9938-4","article-title":"Tgfbi deficiency leads to a reduction in skeletal size and degradation of the bone matrix","volume":"96","author":"Lee","year":"2015","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00223-012-9613-6","article-title":"Targeted disruption of TGFBI in mice reveals its role in regulating bone mass and bone size through periosteal bone formation","volume":"91","author":"Yu","year":"2012","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/dvdy.21812","article-title":"The extracellular matrix protein TGFBI promotes myofibril bundling and muscle fibre growth in the zebrafish embryo","volume":"238","author":"Kim","year":"2009","journal-title":"Dev. Dyn."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ajpath.2015.11.024","article-title":"Initial suppression of transforming growth factor-beta signaling and loss of TGFBI causes early alveolar structural defects resulting in bronchopulmonary dysplasia","volume":"186","author":"Ahlfeld","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0040","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1158\/0008-5472.CAN-08-1648","article-title":"TGFBI deficiency predisposes mice to spontaneous tumor development","volume":"69","author":"Zhang","year":"2009","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2021.110028_bb0045","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.biocel.2007.06.004","article-title":"TGFBIp\/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta","volume":"39","author":"Thapa","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.110028_bb0050","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.3390\/ijms130810461","article-title":"Transforming growth factor-beta-induced protein (TGFBI)\/(betaig-H3): a matrix protein with dual functions in ovarian cancer","volume":"13","author":"Ween","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0055","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/ijc.32247","article-title":"Transforming growth factor beta-induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration","volume":"145","author":"Costanza","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090220","article-title":"betaig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin alpha2beta1 and activating PI3K signaling pathway","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cellsig.2021.110028_bb0065","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.bbamcr.2013.06.012","article-title":"Multiple FAS1 domains and the RGD motif of TGFBI act cooperatively to bind alphavbeta3 integrin, leading to anti-angiogenic and anti-tumor effects","volume":"1833","author":"Son","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.cellsig.2021.110028_bb0070","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1158\/0008-5472.CAN-04-2705","article-title":"Regulation of tumor angiogenesis by fastatin, the fourth FAS1 domain of betaig-h3, via alphavbeta3 integrin","volume":"65","author":"Nam","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2021.110028_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.cellsig.2021.110028_bb0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","article-title":"The roles of microRNAs in epigenetic regulation","volume":"51","author":"Yao","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110028_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s12013-013-9555-2","article-title":"DNA methylation and cancer development: molecular mechanism","volume":"67","author":"Akhavan-Niaki","year":"2013","journal-title":"Cell Biochem. Biophys."},{"issue":"12","key":"10.1016\/j.cellsig.2021.110028_bb0090","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/15592294.2019.1638701","article-title":"DNA hypermethylation in disease: mechanisms and clinical relevance","volume":"14","author":"Ehrlich","year":"2019","journal-title":"Epigenetics"},{"issue":"35","key":"10.1016\/j.cellsig.2021.110028_bb0095","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","article-title":"CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future","volume":"21","author":"Esteller","year":"2002","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041166","article-title":"Defining driver DNA methylation changes in human cancer","volume":"19","author":"Pfeifer","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0105","doi-asserted-by":"crossref","first-page":"10767","DOI":"10.1002\/jcb.28368","article-title":"Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer","volume":"120","author":"Zhang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2021.110028_bb0110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2407-11-66","article-title":"Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma","volume":"11","author":"Caren","year":"2011","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2021.110028_bb0115","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3760\/cma.j.issn.0366-6999.20133015","article-title":"Epigenetic regulation of putative tumor suppressor TGFBI in human leukemias","volume":"127","author":"Fang","year":"2014","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2010.03.025","article-title":"Frequent promoter hypermethylation of TGFBI in epithelial ovarian cancer","volume":"118","author":"Kang","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.cellsig.2021.110028_bb0125","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1158\/0008-5472.CAN-05-2130","article-title":"Epigenetic inactivation of Betaig-h3 gene in human cancer cells","volume":"66","author":"Shao","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110028_bb0130","first-page":"161","article-title":"TGFBI promoter methylation is associated with poor prognosis in lung adenocarcinoma patients","volume":"42","author":"Seok","year":"2019","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0135","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13058-019-1160-x","article-title":"Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer","volume":"21","author":"Palomeras","year":"2019","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110028_bb0145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2013.2913","article-title":"Epigenetic regulation and cancer (review)","volume":"31","author":"Chen","year":"2014","journal-title":"Oncol. Rep."},{"issue":"16","key":"10.1016\/j.cellsig.2021.110028_bb0150","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1111\/febs.12902","article-title":"lncRNA H19\/miR-675 axis represses prostate cancer metastasis by targeting TGFBI","volume":"281","author":"Zhu","year":"2014","journal-title":"FEBS J."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110028_bb0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41389-018-0050-x","article-title":"Dysregulation of the MiR-449b target TGFBI alters the TGFbeta pathway to induce cisplatin resistance in nasopharyngeal carcinoma","volume":"7","author":"Bissey","year":"2018","journal-title":"Oncogenesis"},{"issue":"11","key":"10.1016\/j.cellsig.2021.110028_bb0160","first-page":"3514","article-title":"EFNB2 acts as the target of miR-557 to facilitate cell proliferation, migration and invasion in pancreatic ductal adenocarcinoma by bioinformatics analysis and verification","volume":"10","author":"Zhang","year":"2018","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0165","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1158\/0008-5472.CAN-08-3381","article-title":"Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias","volume":"69","author":"Li","year":"2009","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.cellsig.2021.110028_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111515","article-title":"Discoidin domain receptor 1 contributes to tumorigenesis through modulation of TGFBI expression","volume":"9","author":"Rudra-Ganguly","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2011.04.010","article-title":"TGFBI expression reduces in vitro and in vivo metastatic potential of lung and breast tumor cells","volume":"308","author":"Wen","year":"2011","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0185","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/bjc.2014.33","article-title":"TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients","volume":"110","author":"Pajares","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0190","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ccr.2007.11.014","article-title":"The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxel","volume":"12","author":"Ahmed","year":"2007","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0195","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3892\/or.2015.4324","article-title":"Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells","volume":"34","author":"Hung","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cellsig.2021.110028_bb0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1476-4598-9-130","article-title":"TGFBI expression is associated with a better response to chemotherapy in NSCLC","volume":"9","author":"Irigoyen","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2021.110028_bb0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-11-36","article-title":"\u03b23 integrin modulates transforming growth factor beta induced (TGFBI) function and paclitaxel response in ovarian cancer cells","volume":"11","author":"Tumbarello","year":"2012","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.cellsig.2021.110028_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162698","article-title":"SPARC regulates transforming growth factor Beta induced (TGFBI) extracellular matrix deposition and paclitaxel response in ovarian cancer cells","volume":"11","author":"Tumbarello","year":"2016","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.cellsig.2021.110028_bb0215","first-page":"6996","article-title":"Secreted and cell surface genes expressed in benign and malignant colorectal tumors","volume":"61","author":"Buckhaults","year":"2001","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110028_bb0220","first-page":"561","article-title":"BigH3 protein expression as a marker for breast cancer","volume":"21","author":"Calaf","year":"2008","journal-title":"Int. J. Mol. Med."},{"issue":"492","key":"10.1016\/j.cellsig.2021.110028_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aam6826","article-title":"Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer","volume":"10","author":"Chen","year":"2017","journal-title":"Sci. Signal."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0230","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1159\/000493293","article-title":"Enhanced expression of TGFBI promotes the proliferation and migration of glioma cells","volume":"49","author":"Guo","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cellsig.2021.110028_bb0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-015-0335-z","article-title":"The role of TGFBI (betaig-H3) in gastrointestinal tract tumorigenesis","volume":"14","author":"Han","year":"2015","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146530","article-title":"Largescale transcriptomics analysis suggests over-expression of BGH3, MMP9 and PDIA3 in oral squamous cell carcinoma","volume":"11","author":"He","year":"2016","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.cellsig.2021.110028_bb0245","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41388-018-0165-8","article-title":"C-Jun\/AP-1 overexpression reprograms ERalpha signaling related to tamoxifen response in ERalpha-positive breast cancer","volume":"37","author":"He","year":"2018","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0250","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.bbrc.2008.03.066","article-title":"Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors","volume":"370","author":"Ivanov","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.cellsig.2021.110028_bb0255","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3892\/or.2014.3468","article-title":"Microarray-based detection and expression analysis of extracellular matrix proteins in drugresistant ovarian cancer cell lines","volume":"32","author":"Januchowski","year":"2014","journal-title":"Oncol. Rep."},{"issue":"30","key":"10.1016\/j.cellsig.2021.110028_bb0260","doi-asserted-by":"crossref","first-page":"49944","DOI":"10.18632\/oncotarget.18278","article-title":"Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines","volume":"8","author":"Januchowski","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cellsig.2021.110028_bb0265","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ygyno.2013.12.021","article-title":"POSTN\/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer","volume":"132","author":"Karlan","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"18","key":"10.1016\/j.cellsig.2021.110028_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184483","article-title":"TGFBI protein is increased in the urine of patients with high-grade urothelial carcinomas, and promotes cell proliferation and migration","volume":"20","author":"Lang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0275","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/jid.2014.20","article-title":"TGF-beta-induced (TGFBI) protein in melanoma: a signature of high metastatic potential","volume":"134","author":"Lauden","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.110028_bb0280","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.biocel.2013.05.027","article-title":"Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI","volume":"45","author":"Lee","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010210","article-title":"Massively parallel signature sequencing and bioinformatics analysis identifies up-regulation of TGFBI and SOX4 in human glioblastoma","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0290","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1101\/gad.1632008","article-title":"Extracellular matrix protein betaig-h3\/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation","volume":"22","author":"Ma","year":"2008","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110028_bb0295","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/onc.2015.73","article-title":"Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis","volume":"35","author":"Maeng","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0300","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1245\/s10434-014-4259-4","article-title":"TGFBI expression in cancer stromal cells is associated with poor prognosis and hematogenous recurrence in esophageal squamous cell carcinoma","volume":"23","author":"Ozawa","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2021.110028_bb0305","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-017-2729-9","article-title":"Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma","volume":"137","author":"Pan","year":"2018","journal-title":"J. Neuro-Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0310","first-page":"1","article-title":"Induction and expression of betaig-h3 in pancreatic cancer cells","volume":"1588","author":"Schneider","year":"2002","journal-title":"Biochim"},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0315","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/cas.13403","article-title":"Epirubicin suppresses proliferative and metastatic potential by downregulating transforming growth factor-beta-induced expression in urothelial carcinoma","volume":"109","author":"Shang","year":"2018","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2011.12.011","article-title":"TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor","volume":"79","author":"Shang","year":"2012","journal-title":"Urology"},{"issue":"39","key":"10.1016\/j.cellsig.2021.110028_bb0325","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1038\/s41388-018-0294-0","article-title":"Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1","volume":"37","author":"Al Shareef","year":"2018","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.cellsig.2021.110028_bb0330","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.012385","article-title":"Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3","volume":"11","author":"Shin","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0335","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/jso.25217","article-title":"High stromal transforming growth factor beta-induced expression is a novel marker of progression and poor prognosis in gastric cancer","volume":"118","author":"Suzuki","year":"2018","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.cellsig.2021.110028_bb0340","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.2147\/CMAR.S208984","article-title":"Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells","volume":"11","author":"Zou","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0345","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neo.2017.11.002","article-title":"BIGH3 promotes osteolytic lesions in renal cell carcinoma bone metastasis by inhibiting osteoblast differentiation","volume":"20","author":"Pan","year":"2018","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.cellsig.2021.110028_bb0350","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1111\/cas.13783","article-title":"Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line","volume":"109","author":"Sato","year":"2018","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0355","first-page":"1038","article-title":"VHL-TGFBI signaling is involved in the synergy between 5-aza-2\u2032-deoxycytidine and paclitaxel against human renal cell carcinoma","volume":"22","author":"Shang","year":"2017","journal-title":"J. BUON"},{"issue":"8","key":"10.1016\/j.cellsig.2021.110028_bb0360","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm0895-822","article-title":"Tumour suppression by the human von Hippel-Lindau gene product","volume":"1","author":"Iliopoulos","year":"1995","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2021.110028_bb0370","doi-asserted-by":"crossref","first-page":"6959","DOI":"10.1167\/iovs.11-7771","article-title":"Prevalence of corneal dystrophies in the United States: estimates from claims data","volume":"52","author":"Musch","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cellsig.2021.110028_bb0375","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1756-9966-31-6","article-title":"TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer","volume":"31","author":"Wang","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0380","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.ajpath.2011.12.035","article-title":"Transforming growth factor beta-induced (TGFBI) is an anti-adhesive protein regulating the invasive growth of melanoma cells","volume":"180","author":"Nummela","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"8","key":"10.1016\/j.cellsig.2021.110028_bb0390","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1158\/1541-7786.MCR-11-0600","article-title":"FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and alphavbeta3 integrin","volume":"10","author":"Nam","year":"2012","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.cellsig.2021.110028_bb0400","first-page":"235","article-title":"Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion","volume":"32","author":"Becker","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2021.110028_bb0405","first-page":"4655","article-title":"miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells","volume":"16","author":"Yan","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"9","key":"10.1016\/j.cellsig.2021.110028_bb0410","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.18632\/oncotarget.14659","article-title":"Bigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model","volume":"8","author":"Allaman-Pillet","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.cellsig.2021.110028_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7110446","article-title":"Genome-wide scan for copy number alteration association with relapse-free survival in colorectal cancer with liver metastasis patients","volume":"7","author":"Yang","year":"2018","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0420","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.26608","article-title":"Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies","volume":"59","author":"Turtoi","year":"2014","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cellsig.2021.110028_bb0425","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1021\/pr200527z","article-title":"Identification of novel accessible proteins bearing diagnostic and therapeutic potential in human pancreatic ductal adenocarcinoma","volume":"10","author":"Turtoi","year":"2011","journal-title":"J. Proteome Res."},{"issue":"12","key":"10.1016\/j.cellsig.2021.110028_bb0430","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/1878-0261.12828","article-title":"TGFBI modulates tumour hypoxia and promotes breast cancer metastasis","volume":"14","author":"Fico","year":"2020","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0435","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41419-020-2438-8","article-title":"Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C","volume":"11","author":"Steitz","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cellsig.2021.110028_bb0440","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1245\/s10434-019-07878-8","article-title":"High stromal TGFBI in lung cancer and intratumoral CD8-positive T cells were associated with poor prognosis and therapeutic resistance to immune checkpoint inhibitors","volume":"27","author":"Nakazawa","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.cellsig.2021.110028_bb0445","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.2337\/db15-0638","article-title":"betaig-h3 represses T-cell activation in type 1 diabetes","volume":"64","author":"Patry","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.cellsig.2021.110028_bb0450","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.7150\/thno.51507","article-title":"Metastatic colorectal cancer cells maintain the TGFbeta program and use TGFBI to fuel angiogenesis","volume":"11","author":"Chiavarina","year":"2021","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.cellsig.2021.110028_bb0455","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.cellsig.2021.110028_bb0460","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc2353","article-title":"Integrins in angiogenesis and lymphangiogenesis","volume":"8","author":"Avraamides","year":"2008","journal-title":"Nat. Rev. Cancer"}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656821001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656821001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T22:10:00Z","timestamp":1718748600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656821001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":87,"alternative-id":["S0898656821001170"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2021.110028","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of the extracellular matrix protein TGFBI in cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2021.110028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110028"}}